Generic Name and Formulations:
Fidaxomicin 200mg; tabs.
Merck & Co., Inc.
Indications for DIFICID:
For the treatment of Clostridium difficile-associated diarrhea.
≥18yrs: 200mg twice daily for 10 days.
<18yrs: not established.
Not for treating systemic infections (minimal systemic absorption). Known macrolide allergy. Discontinue if severe hypersensitivity reactions occur. Pregnancy (Cat. B). Nursing mothers.
Nausea, vomiting, abdominal pain, GI hemorrhage, anemia, neutropenia.
Tabs—20, 60, 100 (10x10 blister cards)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Suicide Attempt Risk Among LGB Populations Higher Than Previously Estimated
- Residents Should Take Advantage of Paid Time Off
- Outpatient Engagement May Lower Suicide Attempts in Patients With Fibromyalgia
- Prevalence of Alzheimer Disease, Related Dementia Set to Double
- Forms of Childhood Adversity Related to First-Episode Psychosis Outcomes